Kaycee Sink

Chief Medical Officer

Cogstate, Inc

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kaycee Sink is the Chief Medical Officer at Cogstate, Inc in the United States. Her research focuses on Alzheimer's disease, particularly in the areas of clinical trial design, assessment of patient dependence, and the application of diagnostic criteria. She has contributed to numerous publications addressing challenges and considerations in Alzheimer’s clinical trials, as well as the psychological aspects of cognitive decline.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Michael Malek-Ahmadi

Banner Alzheimer’s Institute

UNITED STATES

View details

Yakeel T. Quiroz, PhD

Associate Professor

Massachusetts General Hospital

UNITED STATES

View details

Michael Gold

Chief R&D Officer

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kaycee Sink

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation.

The Alzheimer’s Disease Cooperative Study – Activities of Daily Living dependence score: revision and validation of an algorithm evaluating patient dependence across the spectrum of AD severity

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations: Proceedings from the Alzheimer's Association Research Roundtable (AARR) Fall 2021 meeting.

Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice.

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations.

Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.

The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).

A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial.

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials.

The relationship between depressive symptoms and subtypes of mild cognitive impairment in post-menopausal women: Results from the Women's Health Initiative Memory Study.

Collaborators (3)

Michael Malek-Ahmadi

Yakeel T. Quiroz, PhD

Michael Gold

Make your next move.